The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant

Journal of Pathology

Volumn 231, Issue 3, 2013, Pages 335-341

  Yamaguchi, Hiroshi ^a,b   Kuboki, Yuko ^a   Hatori, Takashi ^a   Yamamoto, Masakazu ^a   Shimizu, Kyoko ^a   Shiratori, Keiko ^a   Shibata, Noriyuki ^a   Shimizu, Michio ^b   Furukawa, Toru ^a,c  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

^c TOKYO WOMEN S MEDICAL UNIVERSITY MEDICAL CENTER EAST   (Japan)

Author keywords

AKT; GNAS; intraductal neoplasm; IPMN; ITA; ITPN; KRAS; pancreatic cancer; PIK3CA; pyloric gland

Indexed keywords

ARTICLE; CLINICAL FEATURE; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MOLECULAR DYNAMICS; PANCREAS CANCER; PANCREATIC INTRADUCTAL TUBULOPAPILLARY NEOPLASM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PYLORUS; SEQUENCE ANALYSIS; SOMATIC MUTATION; STOMACH GLAND;

AKT; GNAS; INTRADUCTAL NEOPLASM; IPMN; ITA; ITPN; KRAS; PANCREATIC CANCER; PIK3CA; PYLORIC GLAND;

ADENOCARCINOMA, MUCINOUS; AGED; BIOPSY; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; DNA MUTATIONAL ANALYSIS; FEMALE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; PANCREATIC NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-AKT; RAS PROTEINS; TERMINOLOGY AS TOPIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84885399794     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4242     Document Type: Article

References (32)

1. Adsay NV, Fukushima N, Furukawa T, et al., Intraductal neoplasms of the pancreas. In WHO Classification of Tumours of the Digestive System, Bosman FT, Carneiro F, Hruban RH, et al (eds). International Agency for Research on Cancer: Lyon, 2010; 304-313.
2. Hruban RH, Pitman MB, Klimstra DS,. Tumors of the Pancreas. American Registry of Pathology: Washington, DC, 2007.
3. Japanese Pancreas Society. Classification of Pancreatic Carcinoma, 3rd English edn. Kanehara & Co, Ltd: Tokyo, 2012.
4. Albores-Saavedra J, Sheahan K, O'Riain C, et al., Intraductal tubular adenoma, pyloric type, of the pancreas: additional observations on a new type of pancreatic neoplasm. Am J Surg Pathol 2004; 28: 233-238.
5. Nakayama Y, Inoue H, Hamada Y, et al., Intraductal tubular adenoma of the pancreas, pyloric gland type: a clinicopathologic and immunohistochemical study of 6 cases. Am J Surg Pathol 2005; 29: 607-616.
6. Suda K, Hirai S, Matsumoto Y, et al., Variant of intraductal carcinoma (with scant mucin production) is of main pancreatic duct origin: a clinicopathological study of four patients. Am J Gastroenterol 1996; 91: 798-800.
7. Tajiri T, Tate G, Inagaki T, et al., Intraductal tubular neoplasms of the pancreas: histogenesis and differentiation. Pancreas 2005; 30: 115-121.
8. Tajiri T, Tate G, Kunimura T, et al., Histologic and immunohistochemical comparison of intraductal tubular carcinoma, intraductal papillary-mucinous carcinoma, and ductal adenocarcinoma of the pancreas. Pancreas 2004; 29: 116-122.
9. Yamaguchi H, Shimizu M, Ban S, et al., Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2009; 33: 1164-1172.
10. Yamaguchi H, Kuboki Y, Hatori T, et al., Somatic mutations in PIK3CA and activation of AKT in intraductal tubulopapillary neoplasms of the pancreas. Am J Surg Pathol 2011; 35: 1812-1817.
11. Furukawa T, Kuboki Y, Tanji E, et al., Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep 2011; 1: 161.
12. Wu J, Matthaei H, Maitra A, et al., Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med 2011; 3: 92ra66.
13. Landis CA, Masters SB, Spada A, et al., GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 1989; 340: 692-696.
14. Ban S, Naitoh Y, Mino-Kenudson M, et al., Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types. Am J Surg Pathol 2006; 30: 1561-1569.
15. Chetty R, Serra S,. Intraductal tubular adenoma (pyloric gland-type) of the pancreas: a reappraisal and possible relationship with gastric-type intraductal papillary mucinous neoplasm. Histopathology 2009; 55: 270-276.
16. Hoshi T, Imai M, Ogawa K,. Frequent K-ras mutations and absence of p53 mutations in mucin-producing tumors of the pancreas. J Surg Oncol 1994; 55: 84-91.
17. Satoh K, Shimosegawa T, Moriizumi S, et al., K-ras mutation and p53 protein accumulation in intraductal mucin-hypersecreting neoplasms of the pancreas. Pancreas 1996; 12: 362-368.
18. Sessa F, Solcia E, Capella C, et al., Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virchows Arch 1994; 425: 357-367.
19. Matsubara A, Sekine S, Kushima R, et al., Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum. J Pathol 2013; 229: 579-587.
20. Rosai J,. Pancreas and ampullary region. In Rosai and Ackerman's Surgical Pathology., Rosai J, (ed.). Elsevier Inc: Maryland Heights, MO, 2011; 1005-1056.
21. Biankin AV, Kench JG, Dijkman FP, et al., Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma. Pathology 2003; 35: 14-24.
22. Hruban RH, Goggins M, Parsons J, et al., Progression model for pancreatic cancer. Clin Cancer Res 2000; 6: 2969-2972.
23. Xiao HD, Yamaguchi H, Dias-Santagata D, et al., Molecular characteristics and biological behaviours of the oncocytic and pancreatobiliary subtypes of intraductal papillary mucinous neoplasms. J Pathol 2011; 224: 508-516.
24. Nishikawa G, Sekine S, Ogawa R, et al., Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms. Br J Cancer 2013; 108: 951-958.
25. Yamada M, Sekine S, Ogawa R, et al., Frequent activating GNAS mutations in villous adenoma of the colorectum. J Pathol 2012; 228: 113-118.
26. Furukawa T, Kloppel G, Volkan Adsay N, et al., Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch 2005; 447: 794-799.
27. Yamaguchi H, Inoue T, Eguchi T, et al., Fascin overexpression in intraductal papillary mucinous neoplasms (adenomas, borderline neoplasms, and carcinomas) of the pancreas, correlated with increased histological grade. Mod Pathol 2007; 20: 552-561.
28. Samuels Y, Wang Z, Bardelli A, et al., High frequency of mutations of the PIK3CA gene in human cancers. Science 2004; 304: 554.
29. Engelman JA, Chen L, Tan X, et al., Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers. Nature Med 2008; 14: 1351-1356.
30. Adams JR, Xu K, Liu JC, et al., Cooperation between Pik3ca and p53 mutations in mouse mammary tumor formation. Cancer Res 2011; 71: 2706-2717.
31. Stanger BZ, Stiles B, Lauwers GY, et al., Pten constrains centroacinar cell expansion and malignant transformation in the pancreas. Cancer Cell 2005; 8: 185-195.
32. Elghazi L, Weiss AJ, Barker DJ, et al., Regulation of pancreas plasticity and malignant transformation by Akt signaling. Gastroenterology 2009; 136: 1091-1103.